Clinical trial
Assessment of Novel Molecular Markers in Acute Myeloid Leukemia
NCT00900224 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Novel Molecular Markers in Acute Myeloid Leukemia
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2008
- Completion date
- Not reported
- Enrollment
- 529 (actual)
- Sites
- 77
Conditions
As the registry lists them; a condition with its own page is linked.